Literature DB >> 24400427

Emergence of carbapenem-resistant Acinetobacter in a temperate north Indian State.

N K Bali1, B A Fomda1, H Bashir1, D Zahoor1, S Lone1, P A Koul2.   

Abstract

This study aims to determine drug sensitivity, metallo-beta-lactamase (MBL) production and elaboration of bla(OXA)-type carbapenemases in Acinetobacter spp. in a temperate climate area in north India with a heavy influx of tourists. Antimicrobial sensitivity of 165 isolates was performed. Imipenem-resistant isolates were subjected to combined disk (CDT) and double-disk diffusion tests (DDT) for MBL detection. Minimum inhibitory concentration (MIC) and MBL production were tested by Etest. A multiplex polymerase chain reaction (PCR) was performed for the detection of genes encoding bla(OXA)-23 like, bla(OXA-24) like, bla(OXA-51) like and bla(OXA-58) like genes. Ninety-nine (60%) isolates were imipenem-resistant (MICs 2-96 microg/mL). Fifty (50.5%) of the 99 carbapenem-resistant isolates were MBL producers by CDT and 26 (26.3%) by DDT. The majority (77%) of the isolates elaborated bla(OXA-23) and bla(OXA-51) like genes. Forty seven of the 50 MBL-positive isolates harboured bla(OXA-23) like and bla(OXA-51) like genes. MBL-producing Acinetobacter has emerged as a major pathogen in Kashmir with elaboration of bla(OXA-23) and bla(OXA-51) related carbapenemases. This poses a significant challenge for healthcare professionals and policy planners, and needs to be addressed immediately. Primary care physicians treating visitors to Kashmir need to be aware of the situation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24400427     DOI: 10.1080/09674845.2013.11669950

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  6 in total

1.  Drug-resistant gene of blaOXA-23, blaOXA-24, blaOXA-51 and blaOXA-58 in Acinetobacter baumannii.

Authors:  Chenggong Hou; Feng Yang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 2.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Investigation on the genomic diversity of OXA from isolated Acinetobacter baumannii.

Authors:  Zhen Ma; Luqiu Zhou; Hui Wang; Liangping Luo
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia.

Authors:  Li-Yang Hsu; Anucha Apisarnthanarak; Erum Khan; Nuntra Suwantarat; Abdul Ghafur; Paul Anantharajah Tambyah
Journal:  Clin Microbiol Rev       Date:  2016-10-19       Impact factor: 26.132

5.  A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A.

Authors:  Dieter Mitteregger; Julian Wessely; Ivan Barišić; Branka Bedenić; Dieter Kosak; Michael Kundi
Journal:  Pathogens       Date:  2022-04-18

6.  Dissemination of carbapenem resistance and plasmids encoding carbapenemases in Gram-negative bacteria isolated in India.

Authors:  Prasanth Manohar; Sebastian Leptihn; Bruno S Lopes; Ramesh Nachimuthu
Journal:  JAC Antimicrob Resist       Date:  2021-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.